Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102


Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Caldwell RG, Wilson JB, Anderson SJ, Longnecker R.

Immunity. 1998 Sep;9(3):405-11.


Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.

Anderson LJ, Longnecker R.

Blood. 2009 Jan 1;113(1):108-16. doi: 10.1182/blood-2008-06-160937. Epub 2008 Sep 24.


Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.

Swanson-Mungerson MA, Caldwell RG, Bultema R, Longnecker R.

J Virol. 2005 Jun;79(12):7355-62.


Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.

Incrocci R, Hussain S, Stone A, Bieging K, Alt LA, Fay MJ, Swanson-Mungerson M.

Cell Immunol. 2015 Oct;297(2):108-19. doi: 10.1016/j.cellimm.2015.08.001. Epub 2015 Aug 4.


The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo.

Merchant M, Caldwell RG, Longnecker R.

J Virol. 2000 Oct;74(19):9115-24.


Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.

Swanson-Mungerson M, Bultema R, Longnecker R.

J Gen Virol. 2010 Sep;91(Pt 9):2197-202. doi: 10.1099/vir.0.021444-0. Epub 2010 May 19.


The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.

Merchant M, Swart R, Katzman RB, Ikeda M, Ikeda A, Longnecker R, Dykstra ML, Pierce SK.

Int Rev Immunol. 2001;20(6):805-35. Review.


The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor.

Ingham RJ, Raaijmakers J, Lim CS, Mbamalu G, Gish G, Chen F, Matskova L, Ernberg I, Winberg G, Pawson T.

J Biol Chem. 2005 Oct 7;280(40):34133-42. Epub 2005 Aug 8.


Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.

Vrazo AC, Chauchard M, Raab-Traub N, Longnecker R.

PLoS Pathog. 2012;8(4):e1002662. doi: 10.1371/journal.ppat.1002662. Epub 2012 Apr 19.


Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.

Swart R, Ruf IK, Sample J, Longnecker R.

J Virol. 2000 Nov;74(22):10838-45.


Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.

Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J.

J Exp Med. 2001 Aug 6;194(3):255-64.


Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development.

Ikeda A, Merchant M, Lev L, Longnecker R, Ikeda M.

J Immunol. 2004 May 1;172(9):5329-37.

Supplemental Content

Support Center